PA
AGN

Perceptive Advisors’s Allergan plc AGN Stock Holding History

Perceptive Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-155,000
Closed -$41.5M – 217
2016
Q1 		$41.5M Buy
155,000
+10,000
+7% +$2.86M 3.64% 5
2015
Q4 		$45.3M Buy
+145,000
New +$43.2M 3.35% 7
2015
Q3 		– Sell
-59,185
Closed -$18M – 200
2015
Q2 		$18M Buy
59,185
+10,000
+20% +$2.98M 1.08% 22
2015
Q1 		$14.6M Buy
49,185
+34,097
+226% +$9.72M 1.14% 23
2014
Q4 		$3.88M Buy
15,088
+88
+0.6% +$22K 0.33% 63
2014
Q3 		$3.62M Buy
+15,000
New +$3.36M 0.37% 53
2014
Q2 		– Sell
-945
Closed -$195K – 153
2014
Q1 		$195K Buy
+945
New +$187K 0.02% 104

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Perceptive Advisors's AGN Position: Q2 2016 in Review

Perceptive Advisors sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 155,000 shares — an estimated $41.5M sold.

Perceptive Advisors first reported a position in AGN in Q1 2014 and held it in 7 quarters. The position peaked at $45.3M in Q4 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Perceptive Advisors reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Perceptive Advisors sold 155,000 Allergan plc shares in Q2 2016, an estimated $41.5M.
  • Perceptive Advisors first reported a position in Allergan plc in Q1 2014 and held it in 7 quarters.
  • Perceptive Advisors's Allergan plc position peaked at $45.3M in Q4 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Perceptive Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.